← Back to Clinical Trials
Recruiting NCT07303920

NCT07303920 Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07303920
Status Recruiting
Phase —
Sponsor Ohio State University
Condition Astigmatism
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-03-04
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Daily disposable contact lenses for astigmatism

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-03-04 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study to assess the wear experience of people who have astigmatism when wearing a daily disposable contact lens for astigmatism over long days of wear.

Eligibility Criteria

Inclusion Criteria: * Current soft toric contact lens wearer with long hours of wear * Willing to follow the contact lens wearing schedule required by the study * Vision 20/25 or better with current soft toric contact lenses * Self-report completion of a comprehensive eye examination in the past two years Exclusion Criteria: * Have a history of corneal ocular surgery * Have current ocular inflammation or infection as assessed by the study investigator who will complete the study * Are past rigid contact lens wearers * Have a history of being diagnosed with dry eye or ocular allergies * Have known systemic health conditions that are thought to alter tear film physiology * Have a history of viral eye disease * Have a history of ocular surgery * Have a history of severe ocular trauma * Have a history of corneal dystrophies or degenerations * Have active ocular infection or inflammation * Are currently using isotretinoin-derivatives or ocular medications * Are pregnant or breast feeding

Contact & Investigator

Central Contact

Study Coordinators

✉ OPT-EyeStudies@osu.edu

📞 614-292-8858

Frequently Asked Questions

Who can join the NCT07303920 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Astigmatism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07303920 currently recruiting?

Yes, NCT07303920 is actively recruiting participants. Contact the research team at OPT-EyeStudies@osu.edu for enrollment information.

Where is the NCT07303920 trial being conducted?

This trial is being conducted at Columbus, United States.

Who is sponsoring the NCT07303920 clinical trial?

NCT07303920 is sponsored by Ohio State University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology